RecruitingNCT06703918

Study on Clostridium Difficile Infection in Infants

A Retrospective Cohort Study on the Epidemiological Characteristics and Biomarkers of Clostridium Difficile Infection in Infants


Sponsor

First People's Hospital of Hangzhou

Enrollment

150 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.


Eligibility

Min Age: 0 MonthsMax Age: 24 Months

Inclusion Criteria1

  • Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group).

Exclusion Criteria1

  • Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hangzhou First People's Hospital

Hangzhou, Zhejiang, China, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06703918


Related Trials